Connexin 43 inhibition sensitizes chemoresistant glioblastoma cells to temozolomide

Resistance of glioblastoma (GBM) to the front-line chemotherapeutic agent temozolomide (TMZ) continues to challenge GBM treatment efforts. The repair of TMZ-induced DNA damage by O-6-methylguanine-DNA methyltransferase (MGMT) confers one mechanism of TMZ resistance. Paradoxically, MGMT-deficient GBM...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Murphy, Susan F, Varghese, Robin T, Lamouille, Samy, Guo, Sujuan, Pridham, Kevin J, Kanabur, Pratik, Osimani, Alyssa M, Sharma, Shaan, Jourdan, Jane, Rodgers, Cara M, Simonds, Gary R, Gourdie, Robert G, Sheng, Zhi
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113032/
https://ncbi.nlm.nih.gov/pubmed/26542214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-1286
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki